Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences (EMMA) Stock Price, News & Analysis

Emmaus Life Sciences logo
$0.01 +0.00 (+25.23%)
As of 03:04 PM Eastern

About Emmaus Life Sciences Stock (OTCMKTS:EMMA)

Key Stats

Today's Range
$0.0115
$0.0139
50-Day Range
$0.0109
$0.0160
52-Week Range
$0.00
$0.05
Volume
23,715 shs
Average Volume
37,736 shs
Market Capitalization
$887.74 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMMA Stock News Headlines

OpenAI’s new $300 billion deal
OpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next ChatGPT models, and Porter Stansberry says the real opportunity isn’t in flashy AI apps but in the infrastructure behind them — data centers, fiber networks, energy, and more — with eight companies best positioned to profit from this massive shift.tc pixel
Emmaus Life Sciences Inc
See More Headlines

EMMA Stock Analysis - Frequently Asked Questions

Emmaus Life Sciences' stock was trading at $0.0085 at the beginning of 2025. Since then, EMMA shares have increased by 63.5% and is now trading at $0.0139.

Emmaus Life Sciences, Inc. (OTCMKTS:EMMA) released its quarterly earnings data on Thursday, August, 14th. The company reported ($0.02) EPS for the quarter. The business earned $2.82 million during the quarter.

Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emmaus Life Sciences investors own include Humanigen (HGEN), Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Acasti Pharma (ACST), Actinium Pharmaceuticals (ATNM) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
8/14/2025
Today
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EMMA
CIK
822370
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.45 million
Net Margins
-24.20%
Pretax Margin
-28.35%
Return on Equity
N/A
Return on Assets
-14.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.08
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$16.65 million
Price / Sales
0.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.88) per share
Price / Book
-0.01

Miscellaneous

Outstanding Shares
63,870,000
Free Float
41,513,000
Market Cap
$708.96 thousand
Optionable
Not Optionable
Beta
9.01

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:EMMA) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners